Filana Therapeutics Announces Publication of Preclinical Simufilam Findings
Filana Therapeutics announced publication in Cells of preclinical findings for simufilam in TSC2-deficient cells.
Related stories
Godrej Consumer shares fall 2.63% after quarterly profit miss
Godrej Consumer shares fell 2.63% in pre-open trade after quarterly profit missed estimates.
M impact | EQUITY | Oct 30, 2026, 03:40 AM UTC
H2O America Estimates Net Proceeds of Around $315.3M
M impact | EQUITY | Oct 30, 2026, 03:40 AM UTC
India's Nifty Bank futures fall 0.17% pre-open
M impact | EQUITY | Oct 30, 2026, 03:40 AM UTC
Trent shares rise 5.5% in pre-open trade after quarterly profit rise
M impact | EQUITY | Oct 30, 2026, 03:40 AM UTC
India's Nifty 50 futures fall 0.16% in pre-open trade
M impact | EQUITY | Oct 30, 2026, 03:39 AM UTC
H2O America Prices Equity Unit Offering
H2O America announced pricing of an offering of equity units.
M impact | EQUITY | Oct 30, 2026, 03:37 AM UTC